TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Nuchev Pty Ltd ( (AU:NUC) ) has issued an update.
Nuchev Limited announced that H&S Group has exercised Tranche 2 of their Performance Options, resulting in the issuance of 8,749,000 Fully Paid Ordinary Shares to H&S Investments. This move increases H&S’s shareholding in Nuchev from 45.56% to 48.62% and provides Nuchev with $1.9 million, enhancing its financial flexibility to pursue medium-term strategies. The company’s CEO, Nathan Cheong, expressed appreciation for H&S Group’s support, which aligns with Nuchev’s strategic growth objectives.
The most recent analyst rating on (AU:NUC) stock is a Hold with a A$0.14 price target. To see the full list of analyst forecasts on Nuchev Pty Ltd stock, see the AU:NUC Stock Forecast page.
More about Nuchev Pty Ltd
Nuchev is an Australian-based nutritional and wellness business offering products under brands like Oli6®, Bio Practica, and Medicine Tree. The company distributes globally recognized European brands in Australia and New Zealand through bWellness. Nuchev focuses on sourcing world-class ingredients and manufacturing products in leading Australian facilities, ensuring high-quality offerings for consumers.
Average Trading Volume: 32,037
Technical Sentiment Signal: Sell
Current Market Cap: A$22M
Learn more about NUC stock on TipRanks’ Stock Analysis page.